BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8813554)

  • 1. Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors.
    Proska J; Tucek S
    Eur J Pharmacol; 1996 Jun; 305(1-3):201-5. PubMed ID: 8813554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
    Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition between positive and negative allosteric effectors on muscarinic receptors.
    Proska J; Tucek S
    Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria.
    Maass A; Kostenis E; Mohr K
    Eur J Pharmacol; 1995 Jan; 272(1):103-6. PubMed ID: 7713140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.
    Maass A; Mohr K
    Eur J Pharmacol; 1996 Jun; 305(1-3):231-4. PubMed ID: 8813558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors.
    Musílková J; Tucek S
    Neurochem Int; 1995; 27(4-5):337-43. PubMed ID: 8845734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists.
    Lysíková M; Havlas Z; Tucek S
    Neurochem Res; 2001 Apr; 26(4):383-94. PubMed ID: 11495349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.
    Jakubík J; Tucek S
    J Neurochem; 1994 Nov; 63(5):1932-40. PubMed ID: 7931349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinburnine decelerates [3H]N-methylscopolamine binding to recombinant human muscarinic M1-M4 acetylcholine receptors.
    Maksay G; Bíró T; Kiss B
    Eur J Pharmacol; 2004 Jan; 483(2-3):229-32. PubMed ID: 14729111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria.
    Lanzafame A; Christopoulos A; Mitchelson F
    Eur J Pharmacol; 2001 Mar; 416(3):235-44. PubMed ID: 11290374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
    Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: studies with chimeric receptors.
    Ellis J; Seidenberg M
    Mol Pharmacol; 2000 Dec; 58(6):1451-60. PubMed ID: 11093785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
    Franken C; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
    Proska J; Tucek S
    Mol Pharmacol; 1994 Apr; 45(4):709-17. PubMed ID: 8183250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
    Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
    Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of positive cooperativity between strychnine-like allosteric modulators and N-methylscopolamine at muscarinic receptors.
    Jakubík J; Dolezal V
    J Mol Neurosci; 2006; 30(1-2):111-2. PubMed ID: 17192652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and negative allosteric interactions on muscarinic receptors.
    Hejnová L; Tucek S; el-Fakahany EE
    Eur J Pharmacol; 1995 Nov; 291(3):427-30. PubMed ID: 8719429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.